Clinical Pharmacologist
Takeda Development Center Americas, Inc.
Dr. Tom Larson, PhD, is currently a Clinical Pharmacologist in the Oncology Quantitative Clinical Pharmacology group at Takeda Pharmaceuticals. Dr. Larson's primary interests are in the development of anti-cancer therapeutics in pediatrics patients and the development and utilization of models for more robust first in children dose selections. Dr. Larson received his PhD from the Mayo Clinic Graduate School of Biomedical Sciences' Molecular Pharmacology and Experimental Therapeutics program, where he focused on the development of population pharmacokinetic-pharmacodynamic models in oncology. He has been a member of ASCPT since 2018.